Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on December 3rd, 2022%
The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time. . . . → Read More: Infographic – Higher HIV Burden for Women, Girls in Africa
By Alan, on October 4th, 2022%
A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria. . . . → Read More: Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test
By Alan, on June 27th, 2022%
Two developers of tests for infectious diseases are collaborating on a molecular test to detect monkeypox, an emerging international public health concern. . . . → Read More: Diagnostics Companies Partner on Monkeypox Test
By Alan, on May 12th, 2022%
The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes
By Alan, on April 14th, 2022%
A developer of genetically altered insects designed to destroy disease-spreading colonies is set to begin pilot tests of its anti-malarial mosquito line. . . . → Read More: Gates Funds Engineered Malaria Mosquito Pilot Test
By Alan, on January 25th, 2022%
A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round. . . . → Read More: Science/Tech AI Developer Raises $100M in New Funds
By Alan, on December 14th, 2021%
An early-stage clinical trial is underway in South Africa testing the safety of a vaccine in capsule form to prevent Covid-19 disease. . . . → Read More: Oral Covid-19 Vaccine Trial Underway
By Alan, on November 24th, 2021%
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production
By Alan, on August 19th, 2021%
A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine
By Alan, on August 9th, 2021%
A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women. . . . → Read More: Gates Grant Funds HIV-Birth Control Implant
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|